<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04864340</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-PUP-2019-01</org_study_id>
    <nct_id>NCT04864340</nct_id>
  </id_info>
  <brief_title>Clinical Trial Using Pupillometry to Measure Nociception in Healthy Volunteers.</brief_title>
  <official_title>Crossover Randomized Clinical Trial to Evaluate the Effectiveness and Safety of Pupillometry as an Objective Measurement of Nociception in Healthy Volunteers.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pupillometry has been used in healthy volunteers to investigate the usefulness of the pupil&#xD;
      light reflex as an indicator of pain intensity on pressure as a nociceptive stimulus. In this&#xD;
      sense, it is necessary to check if the pupillometry is sensitive to different types or&#xD;
      sources of pain. One of these devices is the Algiscan® portable pupillometer (IdMed,&#xD;
      Marseille, France), which we propose to use in the present study. This pupillometer has&#xD;
      previously been used in healthy volunteers, and in patients admitted to the intensive care&#xD;
      unit, subjected to mechanical ventilation and sedation / analgesia.&#xD;
&#xD;
      This study in healthy volunteers aims to evaluate whether the PDR can be a reliable and&#xD;
      discriminatory measure of the intensity of nociception, applying various types of nociceptive&#xD;
      stimuli. If so, this study could lead to the use of pupillometry as an objective measure of&#xD;
      nociception in settings where patients cannot communicate, such as intensive care areas or&#xD;
      perioperative settings.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 30, 2021</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Pupillary Dilatation Reflex (PDR)</measure>
    <time_frame>Change in Pupillary Dilatation Reflex (PDR) from baseline to +10 minutes (with non-nociceptive procedure (fine touch))</time_frame>
    <description>Measure of Pupillary Dilatation Reflex (PDR) in % obtained by AlgiScan®</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Pupillary Dilatation Reflex (PDR)</measure>
    <time_frame>Change in Pupillary Dilatation Reflex (PDR) from baseline to 20 minutes after tetanic stimulation (by Algiscan®)</time_frame>
    <description>Measure of Pupillary Dilatation Reflex (PDR) in % obtained by AlgiScan® after tetanic stimulation (by Algiscan®)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Pupillary Dilatation Reflex (PDR)</measure>
    <time_frame>Change in Pupillary Dilatation Reflex (PDR) from baseline to 30 minutes after tetanic stimulation (by Algiscan®)</time_frame>
    <description>Measure of Pupillary Dilatation Reflex (PDR) in % obtained by AlgiScan® after tetanic stimulation (by Algiscan®)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Pupillary Dilatation Reflex (PDR)</measure>
    <time_frame>Change in Pupillary Dilatation Reflex (PDR) from baseline to 40 minutes after tetanic stimulation (by Algiscan®)</time_frame>
    <description>Measure of Pupillary Dilatation Reflex (PDR) in % obtained by AlgiScan® after tetanic stimulation (by Algiscan®)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Pupillary Dilatation Reflex (PDR)</measure>
    <time_frame>Change in Pupillary Dilatation Reflex (PDR) from baseline to 50 minutes after tetanic stimulation (by Algiscan®)</time_frame>
    <description>Measure of Pupillary Dilatation Reflex (PDR) in % obtained by AlgiScan® after tetanic stimulation (by Algiscan®)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Pupillary Dilatation Reflex (PDR)</measure>
    <time_frame>Change in Pupillary Dilatation Reflex (PDR) from baseline to + 60 minutes after pressure estimulation</time_frame>
    <description>Measure of Pupillary Dilatation Reflex (PDR) in % obtained by AlgiScan® after pressure estimulation (by algometer Somedic®)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Pupillary Dilatation Reflex (PDR)</measure>
    <time_frame>Change in Pupillary Dilatation Reflex (PDR) from baseline to +70 minutes after pressure estimulation</time_frame>
    <description>Measure of Pupillary Dilatation Reflex (PDR) in % obtained by AlgiScan® after pressure estimulation (by algometer Somedic®)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Pupillary Dilatation Reflex (PDR)</measure>
    <time_frame>Change in Pupillary Dilatation Reflex (PDR) from baseline to +80 minutes after pressure estimulation</time_frame>
    <description>Measure of Pupillary Dilatation Reflex (PDR) in % obtained by AlgiScan® after pressure estimulation (by algometer Somedic®)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Pupillary Dilatation Reflex (PDR)</measure>
    <time_frame>Change in Pupillary Dilatation Reflex (PDR) from baseline to +90 minutes after pressure estimulation</time_frame>
    <description>Measure of Pupillary Dilatation Reflex (PDR) in % obtained by AlgiScan® after pressure estimulation (by algometer Somedic®)</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Nociceptive Pain</condition>
  <condition>Pupillary Light Reflex Lost</condition>
  <condition>Healthy</condition>
  <condition>Pain, Procedural</condition>
  <condition>Gender</condition>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>threshold stimulation (tetanic)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>upper threshold stimulation (tetanic)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>threshold stimulation (pressure)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>upper threshold stimulation (pressure)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>non nociceptive procedure (fine touch)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CE marked medical device</intervention_name>
    <description>Tetanic stimulation</description>
    <arm_group_label>threshold stimulation (tetanic)</arm_group_label>
    <arm_group_label>upper threshold stimulation (tetanic)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Algometer</intervention_name>
    <description>Pressure stimulation</description>
    <arm_group_label>threshold stimulation (pressure)</arm_group_label>
    <arm_group_label>upper threshold stimulation (pressure)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Comparator</intervention_name>
    <description>Non-nociceptive procedure (fine touch)</description>
    <arm_group_label>non nociceptive procedure (fine touch)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subjects of both sexes (balanced)&#xD;
&#xD;
          2. Caucasian race&#xD;
&#xD;
          3. Ages between 25 and 65 years old (balanced, 50% from 25-45 and 50% from 45-65)&#xD;
&#xD;
          4. Body weight within the normal range (Quetelet index: 19-30)&#xD;
&#xD;
          5. Clinical history, physical examination and vital signs within normality&#xD;
&#xD;
          6. Free acceptance to participate, with written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previous history of alcoholism or drug dependence (year prior to the screening visit&#xD;
             or daily alcohol consumption&gt; 40 gr / day for men or&gt; 24 gr / day for women)&#xD;
&#xD;
          2. Significant consumption of stimulating drinks (&gt; 5 coffees, teas, chocolate or cola&#xD;
             drinks / day).&#xD;
&#xD;
          3. Taking any medication in the 15 days prior to the study and / or medicinal plants that&#xD;
             may have an effect on the pupil (beta-blockers, droperidol, metoclopramide, clonidine&#xD;
             ...). Oral contraceptives and paracetamol will be allowed.&#xD;
&#xD;
          4. Pregnancy (β-hCG test).&#xD;
&#xD;
          5. Menstruation and / or dysmenorrhea on the day of the study&#xD;
&#xD;
          6. Family or personal history or clinical evidence of psychiatric, neurological or&#xD;
             ophthalmological problems: anxiety, depression, Parkinson's, glaucoma, dry eyes,&#xD;
             retinal diseases, eye surgery and pupil abnormalities, presenting migraine pathology&#xD;
             and diabetes&#xD;
&#xD;
          7. Pupillary diameter ≥ 5mm&#xD;
&#xD;
          8. Smokers or ex-smokers &lt;6 months.&#xD;
&#xD;
          9. Have participated in a clinical trial in the 3 months prior to the start of this&#xD;
             study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Rosa Ballester, PhD</last_name>
      <email>mballesterv@santpau.cat</email>
    </contact>
    <contact_backup>
      <phone>+34935537855</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>April 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2021</study_first_posted>
  <last_update_submitted>May 17, 2021</last_update_submitted>
  <last_update_submitted_qc>May 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nociceptive Pain</mesh_term>
    <mesh_term>Pain, Procedural</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

